Fig. 4

Establishment of a Glycolysis-Immune Related Prognostic Index (GIRPI) and function enrichment. A–C Kaplan–Meier survival analysis and ROC curves of high-GIRPI and low-GIRPI patients in training cohort (A); testing cohort (B) and entire cohort (C), along with the distribution of risk score and survival status. D GO and KEGG pathway enrichment analysis based on DEGs between high-GIRPI and low-GIRPI subgroups. E The result GSEA pathway annotation. F Construction of predictive nomogram. G Calibration curve of the nomogram at 1, 3, and 5 years. H Assessing prognostic performance of Nomogram by ROC curves